Emu Tracks Emu Oil (Emu Tracks Australasia Pty Ltd)

The label did not include the mandatory declaration for 'sulfites’. Sulfites are required to be declared on the labels of medicines as they may cause adverse reactions in individuals with allergies or sensitivities to such substances. Whilst the undeclared presence of trace amounts of sulfites may pose a safety risk for some consumers, current data suggest that severe adverse reactions due to trace residue of sulfites (such as anaphylaxis) are rare. Therefore, the medicine is unlikely to pose an immediate risk to consumer health and safety.
Additionally, the label and website for the medicine advertised its use in rheumatoid arthritis, chronic or severe conditions, digestive disorders, irritable bowel syndrome, Crohn’s disease, ulcers, depression, mood disorders, cardiovascular disease, osteoarthritis, arthritic conditions and lowering cholesterol levels which are serious conditions that require diagnosis, treatment or supervision by a suitably qualified health professional. This is not permitted for medicines that are available for self-selection without prior evaluation by the TGA. References to these conditions have the potential to lead consumers to delay access to timely medical advice or treatment when required, resulting in adverse outcomes. However, the label of the medicine also warned consumers to see a healthcare professional if symptoms persist. As such, the medicine is unlikely to pose an immediate risk to consumer health and safety.